Evotec SE (EVO) Financials

EVO Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.8 billion 1.0 billion
March 31, 2026 1.9 billion 1.1 billion
Dec. 31, 2025 2.1 billion 1.1 billion
Sept. 30, 2025 2.1 billion 1.1 billion

EVO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -136.4 million ?
March 31, 2026 -7.3 million ?
Dec. 31, 2025 56.5 million ?
Sept. 30, 2025 -104.4 million ?

EVO Net Income

No data available :(

EVO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 531.4 million 292.4 million 180.4 million
March 31, 2026 510.2 million 342.8 million -
Dec. 31, 2025 559.0 million 228.7 million 175.0 million
Sept. 30, 2025 278.4 million 455.0 million -

EVO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 405.8 million
March 31, 2026 407.0 million
Dec. 31, 2025 208.3 million
Sept. 30, 2025 417.0 million

EVO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 10.6 million 11.9 million - -
March 31, 2026 4.8 million 11.7 million 50.2 million -
Dec. 31, 2025 18.2 million 11.5 million 52.1 million -
Sept. 30, 2025 25.1 million 10.2 million 49.7 million -

EVO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 166.5 million 168.3 million
March 31, 2026 182.5 million 184.3 million
Dec. 31, 2025 297.3 million 205.2 million
Sept. 30, 2025 192.3 million 192.4 million

EVO

Price: $1.38

52 week price:
1.35
4.27

Payout Ratio Range:
-118.48%
-19.09%

Earnings Per Share: -0.64 USD

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Germany

Volume: 14985

Market Capitalization: 589.7 million

Links: